DFTX

Definium Therapeutics, Inc. DFTX

NasdaqMid CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$5.34B total
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Debt/Equity

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/DFTX

Earnings Per Share

13fpro.ai/company/DFTX

Loading ratio trend…

About Definium Therapeutics, Inc. (DFTX): stock profile, AI score and financials

Definium Therapeutics, Inc. (DFTX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. DFTX is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. DFTX trades on the Nasdaq exchange and files with the SEC under CIK 1813814. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate DFTX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Definium Therapeutics, Inc. directly from SEC EDGAR.

SEC EDGAR: CIK 1813814 →